---
cover_image: >-
  https://cdn.sanity.io/images/bl383u0v/production/2c96f14f4310e88944511a966a24d42c74de8cc7-8256x5504.jpg?rect=0,584,8256,4334&w=1200&h=630&q=70&fit=crop&auto=format
date: '2025-01-15T23:57:39.000Z'
dateFolder: 2025/01/15
description: >-
  The Federal Trade Commission (FTC) on January 14 released its second report on
  pharmacy benefit managers (PBMs), this time alleging the companies marked up
  prices for cancer, HIV, and other medications by up to “thousands of percent.
isBasedOn: >-
  https://www.healthcare-brew.com/stories/2025/01/15/ftc-pbms-gained-billions-drug-prices-spread-pricing
link: >-
  https://www.healthcare-brew.com/stories/2025/01/15/ftc-pbms-gained-billions-drug-prices-spread-pricing
slug: >-
  2025-01-15-httpswwwhealthcare-brewcomstories20250115ftc-pbms-gained-billions-drug-prices-spread-pricing
tags:
  - healthcare
title: 'FTC: PBMs gained billions by marking up drug prices, spread pricing'
---
The Federal Trade Commission (FTC) on January 14 released its second report on pharmacy benefit managers (PBMs), this time alleging the companies marked up prices for cancer, HIV, and other medications by up to “thousands of percent.
